ArticleScientific reports2025
Biodegradable magnesium-calcium mineralized collagen metal materials inhibits invasion and metastasis of osteosarcoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Osteosarcoma, one of the most common malignant bone tumors in children, carries a mortality rate of 8.6%. Its highly aggressive and metastatic nature, coupled with the severe bone marrow suppression, organ toxicity, and drug resistance associated with conventional radiotherapy, underscores the need for improved therapies. Degradation products from magnesium alloys can modulate the tumor microenvironment and exhibit potential antitumor properties. Consequently, this study examined the application of magnesium-based metallic materials for osteosarcoma treatment, specifically assessing the impact of a magnesium-calcium alloy/mineralized collagen composite on osteosarcoma cell biological behavior. Results demonstrated that the magnesium-calcium alloy/mineralized collagen composite significantly inhibited osteosarcoma cell proliferation, invasion, and metastasis while promoting apoptosis. In vivo experiments further corroborated these findings, revealing that the composite group exhibited the smallest tumor volume, confirming its potent antitumor efficacy against osteosarcoma. Collectively, these findings demonstrate that this biomaterial not only holds significant potential for localized antitumor therapy but also provides a foundational framework that paves the way for novel treatment strategies against osteosarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.